Details for Patent: 9,072,710
✉ Email this page to a colleague
Which drugs does patent 9,072,710 protect, and when does it expire?
Patent 9,072,710 protects CALDOLOR and is included in one NDA.
This patent has fifteen patent family members in twelve countries.
Summary for Patent: 9,072,710
Title: | Injectable ibuprofen formulation |
Abstract: | The present invention provides a pharmaceutical composition comprising an aqueous solution of an ibuprofen solubilizing agent and ibuprofen, the ibuprofen solubilizing agent being in an effective amount such that the ibuprofen in the solution remains soluble at concentrations from 100 mg/mL to 5 mg/mL without undergoing a phase transition. The invention further provides a method of treating a condition chosen from pain, inflammation, fever, and/or patent ductus arteriosis, comprising administering to a patient in need thereof an effective amount of an aqueous solution a ibuprofen solubilizing agent and ibuprofen, the ibuprofen solubilizing agent being in an effective amount such that the ibuprofen in the solution remains soluble at concentrations from 100 mg/mL to 5 mg/mL without undergoing a phase transition, as well as a method for manufacturing the composition. |
Inventor(s): | Pavliv; Leo (Cary, NC), Vila; Andrew (Nashville, TN) |
Assignee: | Cumberland Pharmaceuticals Inc. (Nashville, TN) |
Application Number: | 13/422,761 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 9,072,710
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cumberland Pharms | CALDOLOR | ibuprofen | SOLUTION;INTRAVENOUS | 022348-003 | Jan 25, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | METHODS OF MAKING AQUEOUS COMPOSITION AND TREATING PAIN, INFLAMMATION, FEVER, PATENT DUCTUS ARTERIOSIS WITH AQUEOUS COMPOSITION | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,072,710
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013232038 | ⤷ Try a Trial | |||
Australia | 2016203946 | ⤷ Try a Trial | |||
Canada | 2867477 | ⤷ Try a Trial | |||
Chile | 2014002414 | ⤷ Try a Trial | |||
China | 104302176 | ⤷ Try a Trial | |||
China | 106890137 | ⤷ Try a Trial | |||
Denmark | 2825039 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |